Thirdly, we cannot be certain that changes in CRP levels will necessarily result in significant changes in health outcomes of COPD patients, though there is a body of indirect evidence suggesting that they do [6,14,17]. The gene discussed is CRP; the disease is chronic obstructive pulmonary disease.